デフォルト表紙
市場調査レポート
商品コード
1448559

臨床試験イメージングの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Clinical Trial Imaging Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日: | 発行: Value Market Research | ページ情報: 英文 286 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
臨床試験イメージングの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年02月01日
発行: Value Market Research
ページ情報: 英文 286 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験イメージング市場の世界需要は、2023年の21億9,000万米ドルから2032年には44億1,000万米ドル近くの市場規模に達すると推定され、調査期間2024~2032年のCAGRは8.09%です。

臨床試験イメージングでは、MRI、CT、PETなどのさまざまなイメージング技術を使用して、臨床試験における病状や治療結果を評価・分析します。これらの画像は研究者や臨床医に貴重なデータを提供し、治療効果、病勢進行、患者反応の評価に役立ちます。

市場力学

臨床試験イメージング市場は、臨床試験の複雑化、医療イメージング技術の進歩、医薬品開発における客観的かつ定量的なイメージングデータの需要によって牽引されています。製薬企業やバイオテクノロジー企業が、画像によるエンドポイントを取り入れることで臨床試験の効率と精度を高めようとしていることから、市場は成長を遂げています。画像診断技術により、疾患の進行や治療効果を非侵襲的にモニタリングできるため、早期の意思決定が容易になり、侵襲的な処置の必要性が減少します。さらに、臨床試験における貴重なバイオマーカーとして、規制当局が医療用画像診断を受け入れつつあることも、市場の拡大に寄与しています。精密医療の台頭と標的療法の開発が、適切な患者集団を特定するための画像診断技術の需要をさらに押し上げています。市場はまた、臨床試験手法の進化を反映し、遠隔モニタリングやデータ収集においてイメージングが重要である分散型臨床試験やバーチャル臨床試験の採用にも影響を受けています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、臨床試験イメージングの世界市場における各セグメントを包括的に評価することもできます。臨床試験イメージング産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

臨床試験イメージング市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家は、今後のビジネスチャンスとそれぞれの製品やサービスの対象層を特定するのに役立ちます。

サービス別

  • 臨床試験デザインとコンサルティングサービス
  • 読影と分析サービス
  • 画像診断サービス
  • システムと技術サポートサービス
  • プロジェクトとデータ管理

モダリティ別

  • コンピュータ断層撮影
  • 磁気共鳴画像法
  • X線
  • 超音波
  • 光干渉断層計(OCT)
  • その他

用途別

  • NASH
  • 慢性腎臓病
  • 糖尿病
  • 心血管疾患
  • 眼科
  • 筋骨格系
  • 腫瘍学
  • 消化器病学
  • 小児科
  • その他

用途別

  • バイオテクノロジーと製薬会社
  • 医療機器メーカー
  • 学術・政府研究機関
  • 開発業務受託機関(CRO)
  • その他

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける臨床試験イメージング市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、すべての主要地域における個々の用途セグメントの需要、推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 臨床試験イメージング-産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 臨床試験イメージングの世界市場分析:サービス別

  • サービス別概要
  • 実績データと予測データ
  • サービス別分析
  • 臨床試験デザインとコンサルティングサービス
  • 読影と分析サービス
  • 画像診断サービス
  • システムと技術サポートサービス
  • プロジェクトとデータ管理

第6章 臨床試験イメージングの世界市場分析:モダリティ別

  • モダリティ別概要
  • 実績データと予測データ
  • モダリティ別分析
  • コンピュータ断層撮影
  • 磁気共鳴画像法
  • X線
  • 超音波
  • 光干渉断層計(OCT)
  • その他

第7章 臨床試験イメージングの世界市場分析:用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • NASH
  • 慢性腎臓病
  • 糖尿病
  • 心血管疾患
  • 眼科
  • 筋骨格系
  • 腫瘍学
  • 消化器病学
  • 小児科
  • その他

第8章 臨床試験イメージングの世界市場分析:最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • バイオテクノロジーと製薬企業
  • 医療機器メーカー
  • 学術・政府研究機関
  • 開発業務受託機関(CRO)
  • その他

第9章 臨床試験イメージングの世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 臨床試験イメージング企業の競合情勢

  • 臨床試験イメージング市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • IXICO plc
  • Navitas Life Sciences
  • Resonance Health
  • ProScan Imaging
  • Radiant Sage LLC
  • Medpace
  • Biomedical Systems Corp
  • Cardiovascular Imaging Technologies
  • Intrinsic Imaging
  • BioTelemetry
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service (USD MN)
  • Clinical Trial Design And Consultation Services Market Sales by Geography (USD MN)
  • Reading And Analytical Services Market Sales by Geography (USD MN)
  • Operational Imaging Services Market Sales by Geography (USD MN)
  • System And Technology Support Services Market Sales by Geography (USD MN)
  • Project And Data Management Market Sales by Geography (USD MN)
  • Analysis Market by Modality (USD MN)
  • Computed Tomography Market Sales by Geography (USD MN)
  • Magnetic Resonance Imaging Market Sales by Geography (USD MN)
  • X-Ray Market Sales by Geography (USD MN)
  • Ultrasound Market Sales by Geography (USD MN)
  • Optical Coherence Tomography (OCT) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • NASH Market Sales by Geography (USD MN)
  • CKD Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Cardiovascular Diseases Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Musculoskeletal Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Pediatrics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End Use (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Medical Devices Manufacturers Market Sales by Geography (USD MN)
  • Academic And Government Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Clinical Trial Imaging Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Trial Imaging Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trial Imaging Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Modality
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service (USD MN)
  • Clinical Trial Design And Consultation Services Market Sales by Geography (USD MN)
  • Reading And Analytical Services Market Sales by Geography (USD MN)
  • Operational Imaging Services Market Sales by Geography (USD MN)
  • System And Technology Support Services Market Sales by Geography (USD MN)
  • Project And Data Management Market Sales by Geography (USD MN)
  • Global Market Analysis by Modality (USD MN)
  • Computed Tomography Market Sales by Geography (USD MN)
  • Magnetic Resonance Imaging Market Sales by Geography (USD MN)
  • X-Ray Market Sales by Geography (USD MN)
  • Ultrasound Market Sales by Geography (USD MN)
  • Optical Coherence Tomography (OCT) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • NASH Market Sales by Geography (USD MN)
  • CKD Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Cardiovascular Diseases Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Musculoskeletal Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Pediatrics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End Use (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Medical Devices Manufacturers Market Sales by Geography (USD MN)
  • Academic And Government Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113786

The global demand for Clinical Trial Imaging Market is presumed to reach the market size of nearly USD 4.41 Billion by 2032 from USD 2.19 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

Clinical trial imaging involves the use of various imaging techniques, such as MRI, CTs, and PET, to assess and analyze medical conditions or treatment outcomes in clinical trials. These images provide valuable data for researchers and clinicians, aiding in the evaluation of treatment efficacy, disease progression, and patient response.

MARKET DYNAMICS

The clinical trial imaging market is driven by the increasing complexity of clinical trials, advancements in medical imaging technologies, and the demand for objective and quantitative imaging data in drug development. The market experiences growth as pharmaceutical and biotechnology companies seek to enhance the efficiency and accuracy of clinical trials by incorporating imaging endpoints. Imaging technologies allow for non-invasive monitoring of disease progression and treatment response, facilitating early decision-making and reducing the need for invasive procedures. Additionally, regulatory agencies' increasing acceptance of medical imaging as a valuable biomarker in clinical trials contributes to the market's expansion. The rise in precision medicine and the development of targeted therapies further drive the demand for imaging techniques to identify suitable patient populations. The market is also influenced by the adoption of decentralized and virtual clinical trials, where imaging is crucial in remote monitoring and data collection, reflecting the evolving landscape of clinical trial methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial imaging. The growth and trends of clinical trial imaging industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical trial imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Clinical Trial Design And Consultation Services
  • Reading And Analytical Services
  • Operational Imaging Services
  • System And Technology Support Services
  • Project And Data Management

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • X-Ray
  • Ultrasound
  • Optical Coherence Tomography (OCT)
  • Others

By Application

  • NASH
  • CKD
  • Diabetes
  • Cardiovascular Diseases
  • Ophthalmology
  • Musculoskeletal
  • Oncology
  • Gastroenterology
  • Pediatrics
  • Others

By End Use

  • Biotechnology And Pharmaceutical Companies
  • Medical Devices Manufacturers
  • Academic And Government Research Institutes
  • Contract Research Organizations (CROs)
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Imaging market include IXICO plc, Navitas Life Sciences, Resonance Health, ProScan Imaging, Radiant Sage LLC, Medpace, Biomedical Systems Corp, Cardiovascular Imaging Technologies, Intrinsic Imaging, BioTelemetry. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CLINICAL TRIAL IMAGING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Modality
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY SERVICE

  • 5.1 Overview by Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Service
  • 5.4 Clinical Trial Design And Consultation Services Historic and Forecast Sales by Regions
  • 5.5 Reading And Analytical Services Historic and Forecast Sales by Regions
  • 5.6 Operational Imaging Services Historic and Forecast Sales by Regions
  • 5.7 System And Technology Support Services Historic and Forecast Sales by Regions
  • 5.8 Project And Data Management Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY MODALITY

  • 6.1 Overview by Modality
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Modality
  • 6.4 Computed Tomography Historic and Forecast Sales by Regions
  • 6.5 Magnetic Resonance Imaging Historic and Forecast Sales by Regions
  • 6.6 X-Ray Historic and Forecast Sales by Regions
  • 6.7 Ultrasound Historic and Forecast Sales by Regions
  • 6.8 Optical Coherence Tomography (OCT) Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 NASH Historic and Forecast Sales by Regions
  • 7.5 CKD Historic and Forecast Sales by Regions
  • 7.6 Diabetes Historic and Forecast Sales by Regions
  • 7.7 Cardiovascular Diseases Historic and Forecast Sales by Regions
  • 7.8 Ophthalmology Historic and Forecast Sales by Regions
  • 7.9 Musculoskeletal Historic and Forecast Sales by Regions
  • 7.10. Oncology Historic and Forecast Sales by Regions
  • 7.11 Gastroenterology Historic and Forecast Sales by Regions
  • 7.12 Pediatrics Historic and Forecast Sales by Regions
  • 7.13 Others Historic and Forecast Sales by Regions

8 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY END USE

  • 8.1 Overview by End Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End Use
  • 8.4 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
  • 8.5 Medical Devices Manufacturers Historic and Forecast Sales by Regions
  • 8.6 Academic And Government Research Institutes Historic and Forecast Sales by Regions
  • 8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions
  • 8.8 Others Historic and Forecast Sales by Regions

9 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL IMAGING COMPANIES

  • 10.1. Clinical Trial Imaging Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CLINICAL TRIAL IMAGING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. IXICO plc
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Navitas Life Sciences
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Resonance Health
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. ProScan Imaging
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Radiant Sage LLC
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Medpace
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Biomedical Systems Corp
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Cardiovascular Imaging Technologies
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Intrinsic Imaging
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. BioTelemetry
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies